Sep 21, 20224BIO Capital Portfolio Company Carisma Therapeutics and Sesen Bio Announce Merger Agreement
Jun 8, 20224BIO Capital Portfolio Company Code Biotherapeutics Closes an Oversubscribed $75 Million Series A
Apr 27, 2022Ray Therapeutics Receives $4M in Funding from the California Institute for Regenerative Medicine